DAILY BRIEF: Arctic Wars doc, investments, patents, icebreakers and future food production
All the daily Finnish business news that works: NTRNZ media, Orion, Lunawood, BBS-Bioactive Bone Substitutes, Aker Arctic and VTT make headlines.
Production of COVID-19 vaccine gets boost from Finland
Biotech company Dyadic International and VTT Technical Research Centre of Finland have reported making strides in developing a production platform for therapeutic proteins in a fungal strain that has the potential to deliver medicines – including a coronavirus vaccine – to the public sooner and more affordably.
DAILY BRIEF: Big art win, Finnish expansion, biopharmaceuticals and space tech
All the daily Finnish business news that works: Anton Pitkänen, Airport College International, Paras Biopharma and VTT make headlines.
DAILY BRIEF: Hot new book, startup funding, big investments and university rankings
All the daily Finnish business news that works: Finnish literature, Superhero Capital, Bayer Finland, Stora Enso, Evli and Finnish universities make headlines.
Finnish medical expertise tackles diabetes
Crown CRO and Swedish company Sigrid Therapeutics have agreed to join forces to study prediabetes.
Forendo Pharma receives EUR 4 million in funding
The Finnish drug development company Forendo Pharma has raised four million euros from Vesalius Biocapital III Partners. The funding will be used to further develop Forendo’s portfolio of women’s health solutions.
Oriola wins dose dispensing contract in Sweden
Finnish company Oriola has signed an agreement with the Stockholm County Council (SLL) to engage in dose dispensing co-operation starting in February 2019.
Biohit GastroPanel finds Korean distributer
Finnish biotechology company Biohit and Dow BioMedica have signed an agreement for the distribution of Biohit GastroPanel in Korea.
Orion and Peptonic partner up for health
Finnish Orion and Swedish Peptonic Medical have announced a tech transfer agreement for VagiVital, a product set to be launched next year.
Nexstim goes commercial with new funding
Medical technology company Nexstim is raising 1.75 million euros in equity financing via a directed issue of new shares to a UK-based fund.